Castellanos-Moreira, R., Gómez, A., Haro Villar, I., Ruiz-Esquide, V., Marsal, V., & Sanmartí, R. (2021). Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.
Citación estilo ChicagoCastellanos-Moreira, R., A. Gómez, Isabel Haro Villar, V. Ruiz-Esquide, V. Marsal, y Raimon Sanmartí. Anti-carbamylated Protein Antibodies Are Associated With Early Abatacept Response in Rheumatoid Arthritis Comment On: Anti-carbamylated Protein Antibodies As a Clinical Response Predictor in Rheumatoid Arthritis Patients Treated With Abatacept. 2021.
Cita MLACastellanos-Moreira, R., et al. Anti-carbamylated Protein Antibodies Are Associated With Early Abatacept Response in Rheumatoid Arthritis Comment On: Anti-carbamylated Protein Antibodies As a Clinical Response Predictor in Rheumatoid Arthritis Patients Treated With Abatacept. 2021.